Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00677235 · ClinicalTrials.gov registry record · NA
Post-Approval Study for the FLAIR Endovascular Stent Graft
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
NCT00677235 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 270 participants.
The verdict
NCT00677235, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
Study Summary
The purpose of this study is to confirm the long-term safety and effectiveness of the FLAIR Endovascular Stent Graft for treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous (AV) access grafts.
Interventions
- DEVICE FLAIR Endovascular Stent Graft
- PROCEDURE PTA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00677235
The ClinicalTrials.gov registry entry for NCT00677235 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FLAIR Endovascular Stent Graft is the first listed.
NCT00677235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00677235 about?
NCT00677235 is a clinical study titled "Post-Approval Study for the FLAIR Endovascular Stent Graft". The purpose of this study is to confirm the long-term safety and effectiveness of the FLAIR Endovascular Stent Graft for treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous (AV) access grafts.
What is the current status of trial NCT00677235?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2008-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00677235?
The interventions under investigation include: FLAIR Endovascular Stent Graft (DEVICE), PTA (PROCEDURE).
Who is sponsoring clinical trial NCT00677235?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.